切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2018, Vol. 12 ›› Issue (11) : 609 -613. doi: 10.3877/cma.j.issn.1674-0785.2018.11.004

所属专题: 文献

临床研究

miRNA-224-5p通过TGF-β/Smad4信号通路调控甲状腺乳头状癌细胞凋亡
马楠1, 徐蓉2, 苏鹏程1,()   
  1. 1. 830000 乌鲁木齐,新疆维吾尔自治区人民医院乳腺、甲状腺科
    2. 830000 乌鲁木齐,新疆维吾尔自治区人民医院肿瘤科
  • 收稿日期:2018-03-11 出版日期:2018-06-01
  • 通信作者: 苏鹏程

MiRNA-224-5p regulates apoptosis of papillary thyroid carcinoma cells via the transforming growth factor beta/Smad4 signaling pathway

Nan Ma1, Rong Xu2, Pengcheng Su1,()   

  1. 1. Department of Mammary and Thyroidology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China
    2. Department of Oncology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China
  • Received:2018-03-11 Published:2018-06-01
  • Corresponding author: Pengcheng Su
  • About author:
    Corresponding author: Su Pengcheng, Email:
引用本文:

马楠, 徐蓉, 苏鹏程. miRNA-224-5p通过TGF-β/Smad4信号通路调控甲状腺乳头状癌细胞凋亡[J]. 中华临床医师杂志(电子版), 2018, 12(11): 609-613.

Nan Ma, Rong Xu, Pengcheng Su. MiRNA-224-5p regulates apoptosis of papillary thyroid carcinoma cells via the transforming growth factor beta/Smad4 signaling pathway[J]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(11): 609-613.

目的

探讨miRNA-224-5p通过TGF-β/Smad4信号通路对甲状腺乳头状癌细胞凋亡的调控作用。

方法

选取2015年7月至2017年11月新疆维吾尔自治区人民医院手术切除所得甲状腺乳头状癌组织及相应的癌旁组织冻存标本各60份。通过逆转录聚合酶链反应(RT-PCR)分别检测60例甲状腺乳头状癌组织及60例癌旁组织中miRNA-224-5p的相对表达量,二者比较采用配对资料t检验。将miRNA-224-5p(miRNA-224-5p组)与miRNA-224-5p抑制剂(miRNA-224-5p抑制剂组)分别转染到甲状腺乳头状癌细胞株GLAG-66中,通过RT-PCR检测两组中GLAG-66细胞内miRNA-224-5p的相对表达量,应用流式细胞仪检测两组GLAG-66细胞转染48 h后凋亡率,应用Western blot实验检测两组GLAG-66细胞中Bcl-2、Bax、Cleaved-Caspase3、TGF-β1、Smad4蛋白的相对表达量,并采用两个独立样本t检验进行比较。

结果

miRNA-224-5p在甲状腺乳头状癌组织中的相对表达量与癌旁组织比较明显升高,差异具有统计学意义[(4.175±0.523)vs(1.236±0.236),t=9.675,P=0.001)]。miRNA-224-5p抑制剂组GLAG-66细胞中miRNA-224-5p的相对表达量与miRNA-224-5p组比较明显下降,差异具有统计学意义[(0.381±0.078)vs(1.000±0.023),t=19.785,P<0.001)]。miRNA-224-5p抑制剂组GLAG-66细胞转染48 h后的凋亡率与miRNA-224-5p组比较明显增高,差异具有统计学意义[(18.66%±0.98%)vs(3.78%±0.36%),t=17.561,P<0.001]。miRNA-224-5p抑制剂组和miRNA-224-5p组比较,GLAG-66细胞中Bcl-2、TGF-β1和Smad4蛋白的相对表达量明显降低,差异具有统计学意义[(0.197±0.008)vs(0.278±0.013),t=8.259,P=0.001;(0.117±0.013)vs(0.227±0.012),t=13.269,P<0.001;(0.268±0.012)vs(0.439±0.016),t=9.897,P=0.001];Bax、Cleaved-Caspase3蛋白的相对表达量明显升高,差异具有统计学意义[(0.286±0.011)vs(0.159±0.009),t=12.569,P<0.001;(0.128±0.009)vs(0.083±0.010),t=7.693,P=0.002]。

结论

miRNA-224-5p在甲状腺乳头状癌组织中表达增高,下调miRNA-224-5p可以促进甲状腺乳头状癌细胞的凋亡,其作用机制可能与TGF-β/Smad4信号通路有关。

Objective

To explore the role of miRNA-224-5p in the apoptosis of papillary thyroid carcinoma cells and the underlying mechanism.

Methods

The expression of miRNA-224-5p in 60 cases of papillary thyroid carcinoma and adjacent tissue was detected by RT-PCR. Human papillary thyroid carcinoma GLAG-66 cells were cultured, miRNA-224-5p and miRNA-224-5p inhibitor were transfected into cells, and the expression of miRNA-224-5p was detected by RT-PCR. Cell apoptosis was detected by flow cytometry 48 h later. The expression of Bcl-2, Bax, Cleaved-Caspase3, TGF-β1, and Smad4 proteins was detected by Western blot.

Results

The expression of miRNA-224-5p in papillary thyroid carcinoma tissue was significantly higher than that in paracancerous tissue [(4.175±0.523) vs (1.236±0.236), t=9.675, P=0.001], and the expression of miRNA-224-5p was significantly lower in the miRNA-224-5p inhibitor group than in the miRNA-224-5p group [(0.381±0.078) vs (1.000±0.023), t=19.785, P<0.001)]. Compared with the miRNA-224-5p group, the apoptosis rate significantly increased in the miRNA-224-5p inhibitor group [(18.66%±0.98%) vs (3.78%±0.36%), t=17.561, P<0.001]. Compared with the miRNA-224-5p group, the expression of Bcl-2, TGF-β1 and Smad4 in the miRNA-224-5p inhibitor group was significantly decreased [(0.197±0.008) vs (0.278±0.013), t=8.259, P=0.001; (0.117±0.013) vs (0.227±0.012), t=13.269, P<0.001; (0.268±0.012) vs (0.439±0.016), t=9.897, P=0.001], and the expression of Bax and Cleaved-Caspase3 protein was significantly increased [(0.286±0.011) vs (0.159±0.009), t=12.569, P<0.001; (0.128±0.009) vs (0.083±0.010), t=7.693, P=0.002].

Conclusion

MiRNA-224-5p is highly expressed in papillary thyroid carcinoma, and down-regulation of miRNA-224-5p promotes cell apoptosis via mechanisms possibly related to regulation of the TGF-β/Smad4 signaling pathway.

表1 miRNA-224-5p抑制剂组和miRNA-224-5p组GLAG-66细胞中Cleaved-Caspase3,Bcl-2,Bax蛋白相对表达量比较(±s
图1 miRNA-224-5p抑制剂组和miRNA-224-5p组GLAG-66细胞中Cleaved-Caspase3,Bcl-2,Bax蛋白表达情况
表2 miRNA-224-5p抑制剂组和miRNA-224-5p组GLAG-66细胞中TGF-β1、Smad4蛋白相对表达量比较(±s
图2 miRNA-224-5p抑制剂组和miRNA-224-5p组GLAG-66细胞中TGF-β1、Smad4蛋白表达情况
1
Bozorg-Ghalati F, Hedayati M. Molecular biomarkers of anaplastic thyroid carcinoma [J]. Curr Mol Med, 2017, 17(3):181-188.
2
Fang W, Bartel DP.The menu of features that define primary microRNAs and enable de novo design of microRNA genes [J]. Mol Cell, 2015, 60(1):131-145.
3
Lima CR, Geraldo MV, Fuziwara CS,et al.MiRNA-146b-5p upregulates migration and invasion of different papillary thyroid carcinoma cells [J]. BMC Cancer, 2016, 16:108.
4
Liu G, Wu K, Sheng Y. Elucidation of the molecular mechanisms of anaplastic thyroid carcinoma by integrated miRNA and mRNA analysis [J]. Oncol Rep, 2016, 36(5):3005-3013.
5
Tao L, Bei Y, Chen P, et al. Crucial role of miR-433 in regulating cardiac fibrosis [J]. Theranostics, 2016, 6(12):2068-2083.
6
Wang H, Bei Y, Huang P, et al. Inhibition of miR-155 protects against LPS-induced cardiac dysfunction and apoptosis in mice [J]. Mol Ther Nucleic Acids, 2016, 5(10):e374.
7
Shi J, Bei Y, Kong X, et al. miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury [J]. Theranostics, 2017, 7(3):664-676.
8
Zhang K, Song F, Lu X, et al. MicroRNA-322 inhibits inflammatory cytokine expression and promotes cell proliferation in LPS-stimulated murine macrophages by targeting NF-κB1 (p50) [J]. Biosci Rep, 2017, 37(1). pii: BSR20160239.
9
Zhou J, Hu M, Wang F, et al. miR-224 controls human colorectal cancer cell line HCT116 proliferation by targeting Smad4 [J]. Int J Med Sci, 2017, 14(10):937-942.
10
Zhang Y, Guo CC, Guan DH, et al. Prognostic value of microRNA-224 in various cancers:a meta-analysis [J]. Arch Med Res, 2017, 48(5):472-482.
11
Xue J, Lin X, Chiu WT, et al. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis [J]. J Clin Invest, 2014, 124(2):564-579.
12
Yoon HN, Yoon SY, Hong JH, et al. A mutation in keratin 18 that causes caspase-digestion resistance protects homozygous transgenic mice from hepatic apoptosis and injury [J]. J Cell Sci, 2017, 130(15):2541-2550.
13
Zhang Z, Zhang S, Wang Y, et al. Autophagy inhibits high glucose induced cardiac microvascular endothelial cells apoptosis by mTOR signal pathway [J]. Apoptosis, 2017, 22(12):1510-1523.
14
Alarifi S, Ali H, Alkahtani S, et al. Regulation of apoptosis through bcl-2/bax proteins expression and DNA damage by nano-sized gadolinium oxide [J]. Int J Nanomedicine, 2017, 12:4541-4551.
15
Ma J, Zhao D, Lu H, et al. Apoptosis signal-regulating kinase 1 (ASK1) activation is involved in silver nanoparticles induced apoptosis of A549 lung cancer cell line [J]. J Biomed Nanotechnol, 2017, 13(3):349-354.
16
Messer JS. The cellular autophagy/apoptosis checkpoint during inflammation [J]. Cell Mol Life Sci, 2017, 74(7):1281-1296.
17
Sharma S, Kaufmann T, Biswas S.Impact of inhibitor of apoptosis proteins on immune modulation and inflammation [J]. Immunol Cell Biol, 2017, 95(3):236-243.
18
Zhao C, Zhao Q, Zhang C, et al. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis [J]. Sci Rep, 2017, 7(1):4194.
19
Zhou J, Hu M, Wang F, et al. miR-224 controls human colorectal cancer cell line HCT116 proliferation by targeting Smad4 [J]. Int J Med Sci, 2017,14(10):937-942.
20
Zheng X, Tang H, Zhao X, et al. Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p [J]. PloS one, 2017, 12(11):e0184746.
21
He X, Zhang Z, Li M, et al. Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma [J]. BMC Cancer, 2015, 15:575.
22
Ahmed S, Bradshaw AD, Gera S, et al.The TGF-β/Smad4 signaling pathway in pancreatic carcinogenesis and its clinical significance [J]. J Clin Med, 2017, 6(1).pii: E5.
23
Kouraklis G, Kakisis J, Theoharis S, et al. Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer [J].Dig Dis Sci, 2003, 48(12):2284-2289.
24
Zhao B, He T. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer [J]. Oncol Rep, 2015, 33(1):304-310.
25
Vizetto-Duarte C, Custódio I, Gangadhar KN, et al. Isololiolide, a carotenoid metabolite isolated from the brown alga Cystoseira tamariscifolia, is cytotoxic and able to induce apoptosis in hepatocarcinoma cells through caspase-3 activation, decreased Bcl-2 levels, increased p53 expression and PARP cleavage [J]. Phytomedicine, 2016, 23(5):550-557.
[1] 陈启阳, 刘玉江, 刘金苹, 谭小蕖, 钱林学, 胡向东. 基于超声造影的预测模型对甲状腺乳头状癌颈中央区淋巴结转移的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(04): 442-448.
[2] 李素娟, 丁文波, 武心萍, 邓学东. 被膜侵犯的甲状腺微小乳头状癌发生颈部淋巴结转移的超声相关危险因素分析[J]. 中华医学超声杂志(电子版), 2023, 20(04): 455-461.
[3] 李康, 冀亮, 赵维, 林乐岷. 自噬在乳腺癌生物学进展中的双重作用[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 195-202.
[4] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[5] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[6] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[7] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[8] 刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[9] 邓春文, 陈嵩, 钟裴, 闵师强, 万健. LncRNA CRNDE通过miR-181a-5p/SOX6轴调节脂多糖诱导人肺泡上皮细胞的炎症反应和细胞凋亡[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 129-136.
[10] 余慧, 王静, 杜丹, 杨帆. 下调miR-301a-3p抑制人卵巢颗粒KGN细胞增殖和诱导凋亡的机制研究[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 137-143.
[11] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[12] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[13] 张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
[14] 郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要